VSIR and malignant colon neoplasm: Anti-VISTA therapy has increased infiltration of CD8+ and CD4+ T cells into the TME in a CT26 colon cancer mouse xenograft model, likely due to eliminating the inhibitory signals from VISTA on MDSCs (41).